Track PMVP and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
PMVP - Pmv Pharmaceuticals Inc (PMVP) has a free cash flow of -$73.61M, down 41.7% over the past year and down 97.0% per year over the past five years.
FCF TTM
-$73.61M
FCF Margin
-
FCF Yield
-102.04%
5Y CAGR
-96.99%
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$73.61M | -41.72% |
| 2024 | -$51.94M | +8.27% |
| 2023 | -$56.62M | +21.08% |
| 2022 | -$71.74M | -49.72% |
| 2021 | -$47.92M | -45.71% |
| 2020 | -$32.89M | -48.31% |
| 2019 | -$22.17M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q4 2025 | -$17.20M | +13.19% |
| Q3 2025 | -$19.82M | -8.22% |
| Q2 2025 | -$18.31M | -0.24% |
| Q1 2025 | -$18.27M | -9.29% |
| Q4 2024 | -$16.72M | +0.73% |
| Q3 2024 | -$16.84M | -951.19% |
| Q2 2024 | -$1.60M | +90.45% |
| Q1 2024 | -$16.78M | -36.61% |
| Q4 2023 | -$12.28M | +21.79% |
| Q3 2023 | -$15.70M | -16.61% |
| Q2 2023 | -$13.47M | +11.22% |
| Q1 2023 | -$15.17M | +10.58% |
| Q4 2022 | -$16.96M | +9.82% |
| Q3 2022 | -$18.81M | -9.49% |
| Q2 2022 | -$17.18M | +8.59% |
| Q1 2022 | -$18.79M | -52.92% |
| Q4 2021 | -$12.29M | +4.72% |
| Q3 2021 | -$12.90M | -32.88% |
| Q2 2021 | -$9.71M | +25.47% |
| Q1 2021 | -$13.02M | -25.61% |
| Q4 2020 | -$10.37M | -39.50% |
| Q3 2020 | -$7.43M | -7.79% |
| Q2 2020 | -$6.90M | +15.79% |
| Q1 2020 | -$8.19M | -59.72% |
| Q4 2019 | -$5.13M | +10.60% |
| Q3 2019 | -$5.74M | -1.40% |
| Q2 2019 | -$5.66M | +0.00% |
| Q1 2019 | -$5.66M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.